tivated HSV antigens. Higher stimulation indexes were obtained when lymphocytes were incubated with the homologous as compared with the heterologous antigen. Higher mean lymphocyte stimulation indexes were also demonstrated in seropositive as compared with seronegative individuals. Lymphocytes from children with HSV-1 stomatitis usually became responsive to HSV-1 antigen within 2 to 6 weeks after the onset of illness. Lymphocytes from infants with neonatal HSV-2 infection were stimulated by HSV-2 antigen.
A number of clinical and experimental animal observations suggest that cellular mechanisms play an important role in immunity to herpes .simplex virus (HSV) infection (4) . To permit more finite studies, several in vitro assays for cell-mediated immunity to HSV, including assays for lymphocyte transformation, are currently being developed. Stimulation by inactivated HSV antigens of spleen lymphocytes obtained from HSV-inoculated rabbits was demonstrated by Rosenberg and co-workers (6, 7) . Several investigators have also reported that HSV-1 antigens stimulate peripheral blood lymphocytes obtained from adults with recurrent HSV-1 infections (5, 8, 9) .
The purpose of the present study was to characterize further the transformation of lymphocytes obtained from seronegative individuals and from those with primary, as well as recurrent, HSV-1 infections. In addition, the response to HSV-2 antigens was studied in both adults and newborns.
MATERIALS AND METHODS Preparation of antigens. HSV antigens were prepared from HSV-infected BHK-21 cells. Crude virus pools were partially purified by two 1-h centrifugations at 100,000 x g. The pelleted viruses were resuspended in pH 7.2 phosphate-buffered saline containing penicillin, streptomycin, and fungizone, and were placed in a 56 C water bath for 1 h. Before heat inactivation, the HSV-1 (HE newborn strain) and HSV-2 (FLO newborn strain) preparations contained 3 x 108 and 8 x 107 plaque-forming units per ml, respectively; inactivated preparations contained no infectious virus. BHK antigen was prepared from uninfected BHK-21 cells treated in the same fashion. All antigens were stored at -70 C before use.
Leukocyte cultures. Peripheral blood was drawn into syringes containing 50 to 100 U of heparin (Panheprin, Abbott Laboratories, North Chicago, Ill.) per ml of blood. Macrodex (6% vol/wt) (Pharmacia Laboratories, Inc., Piscataway, N.J.) was added to give a final concentration of 1%, and the blood was allowed to sediment at 37 C for 1 were obtained from twelve healthy adults, six with no detectable HSV antibodies and six with HSV-1 antibodies. None of the individuals had herpetic lesions around the time their lymphocytes were tested with the HSV-1 and BHK antigens. The geometric mean SI for seropositive individuals (1.44 ± .46) was significantly higher (P < 0.01) than that obtained for seronegative individuals (0.52 + 0.41). SIs of 11.0, 7.3, and 4.7 were obtained with lymphocytes from three of the seronegative subjects who denied having experienced prior HSV infection. One of these individuals (SI = 4.7) subsequently developed HSV-1 stomatitis; HSV-1 antibodies were detected 10 days after the onset of illness.
Response of lymphocytes from children with HSV-1 stomatitis. Four children, ages 1 to 3 years, with virologically confirmed HSV-1 stomatitis had their lymphocytes assayed at the time of their first clinic visit and 2 to 6 weeks later ( Table 2 ). All of the children demonstrated typical herpetic oral lesions, cervical adenopathy, and fever, and had been symptomatic for 3 to 6 days prior to initial examination. At the time of repeat testing, all showed complete healing of the lesions. The lymphocytes obtained at the time of the first visit, when incubated with the HSV-1 and BHK antigens, yielded a geometric mean SI of 0.25 4 0.28. Two to 6 weeks later, the geometric mean SI (1.16 ± 0.67) was significantly increased (P < 0.01). The lymphocytes from one patient (no. 1) failed to respond when tested 22 days postinfection, although serum HSV antibodies were detected at that time. Another child (no. 4) demonstrated a low SI 6 days after onset of clinical manifestations, at which time HSV antibodies were already present in his serum.
Lymphocyte stimulation in infants with neonatal HSV-2 infection. Two infants with neonatal HSV-2 infection documented by viral isolation and typing were studied 3 weeks and 1 Lymphocytes from every individual tested could not be incubated with multiple concentrations of antigens or with mitogens as amounts of blood which could be easily obtained, particularly from infants, were not sufficient. We are currently adapting the assay to a micromethod which would permit testing the (5) . However, in our study, lymphocytes from two children failed to demonstrate transformation at a time when serumf HSV-1 antibodies were detected. Since lymphocytes were not incubated with mitogens, we cannot rule out the possibility that transient diminished lymphocyte responsiveness, which has been described with some viral infections, was responsible for these findings.
As has been noted in previous studies (5, 8, 9) The lymphocyte stimulation assay may assist in the retrospective diagnosis of herpetic infections in newborns which are caused primarily by HSV-2, particularly if the greater reactivity obtained with the HSV-2 antigen is a consistent phenomenon. This neonatal infection is difficult to diagnose when skin lesions are absent or when virus is not recoverable from accessible sites (1) . The lymphocyte assay may therefore prove to be useful for early detection of neonatal HSV infection.
